MKI67 and hepatocellular carcinoma: To predict the prognosis of HCC patients, a nomogram was developed based on the training cohort that integrated the PA-TACE timing with significant clinical characteristics, such as Ki-67, tumor size and MVI, for RFS (Figure 4A).